レジオネラ検査市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、最終用途別（微生物培養、直接蛍光抗体染色、PCR、その他）、地域別、競合別、2020-2030F

レジオネラ検査の世界市場は、2024年に2億8,425万米ドルと評価され、予測期間中のCAGRは9.39%で、2030年には4億8,715万米ドルに達すると予測されています。

レジオネラ検査世界市場とは、レジオネラ菌、特にレジオネラ症を引き起こす原因菌であるLegionella pneumophila（レジオネラ・ニューモフィラ）の検出と監視に使用される診断検査とサービスの市場を指します。レジオネラ症は重症の肺炎であり、冷却塔、温水浴槽、配管システムなどから発生する汚染された水滴を吸入することで感染します。疾病対策予防センターによると、2018年には約10,000件のレジオネラ症が報告されました。

レジオネラ菌は温水環境で繁殖するため、学校、レストラン、病院、大規模な配管システムなど、貯水に依存する産業は特にレジオネラ汚染の影響を受けやすいです。その結果、レジオネラ菌および関連感染症の正確かつタイムリーな診断に対する需要が、これらの業界全体で高まっています。2022年9月、アルゼンチンのサン・ミゲル・デ・トゥクマンで重度の肺炎が発生し、4人が死亡、11人が重症化しました。この集団発生は後にレジオネラ、特にL.pneumophila菌に関連していました。さらに2022年6月には、ニューヨーク州司法長官がベライゾンと合意に達し、同社がニューヨーク州全域でレジオネラ症の蔓延を防ぐために迅速かつ包括的な行動を取ることを確認しました。

主な市場促進要因

検査技術の進歩

主な市場課題

標準化された検査プロトコルの欠如

主な市場動向

迅速診断検査

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のレジオネラ検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（水質検査、体外診断検査）
  • 用途別（微生物培養、直接蛍光抗体（DFA）染色、PCR、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • タイプ別
  • 最終用途別
  • 地域別

第6章 北米のレジオネラ検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のレジオネラ検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域のレジオネラ検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米のレジオネラ検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのレジオネラ検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Abbott Laboratories
• Beckman Coulter, Inc.
• Bio-Rad Laboratories Inc.
• BIOMERIEUX SA
• Eiken Chemical Co., Ltd
• Hologic Inc.
• Pro-Lab PLC
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Legionella Testing Market was valued at USD 284.25 million in 2024 and is expected to reach USD 487.15 million by 2030 with a CAGR of 9.39% during the forecast period. The Global Legionella Testing Market refers to the market for diagnostic tests and services used to detect and monitor Legionella bacteria, particularly the Legionella pneumophila species, responsible for causing Legionnaires' disease. Legionnaires' disease is a severe form of pneumonia that can be contracted through inhalation of contaminated water droplets, typically from sources like cooling towers, hot tubs, and plumbing systems. According to the Centers for Disease Control and Prevention, approximately 10,000 cases of Legionnaires' disease were reported in 2018.

Legionella bacteria thrive in hot water conditions, making industries that rely on water storage, such as schools, restaurants, hospitals, and large plumbing systems, particularly susceptible to Legionella contamination. As a result, there is a growing demand across these industries for accurate and timely diagnosis of Legionella and related infections. In September 2022, an outbreak of severe pneumonia in San Miguel de Tucuman, Argentina, resulted in four deaths and 11 cases of severe illness. This outbreak was later linked to Legionella, specifically the bacterium L. pneumophila. Additionally, in June 2022, the New York Attorney General reached an agreement with Verizon to ensure the company takes swift and comprehensive action to prevent the spread of Legionnaires' disease throughout New York State.

Key Market Drivers

Advances in Testing Technologies

The Global Legionella Testing Market is experiencing substantial growth, and one of the key drivers behind this expansion is the continuous advancement of testing technologies. Legionella, a bacterium responsible for Legionnaires' disease, poses a significant public health risk. The need for rapid, sensitive, and accurate testing methods has driven innovation in the field.

Traditional methods of detecting Legionella bacteria, such as culture-based techniques, can be time-consuming and may not always yield accurate results. In contrast, modern molecular techniques, particularly Polymerase Chain Reaction (PCR), have revolutionized Legionella testing. PCR allows for the rapid and precise detection of Legionella DNA in water and environmental samples, significantly reducing the time required for diagnosis. The ability to provide quicker and more accurate results is a key factor driving the demand for Legionella testing services.

The sensitivity of testing methods is crucial when dealing with potentially harmful microorganisms like Legionella. Advances in testing technologies have led to the development of highly sensitive assays. These assays can detect even trace amounts of Legionella bacteria in various samples, including water systems, cooling towers, and air. Enhanced sensitivity ensures that potential sources of contamination are not overlooked, thereby improving the overall safety of water systems.

Automation in testing technologies has not only sped up the testing process but has also minimized the potential for human error. Automated platforms reduce the manual handling of samples, leading to greater consistency and reliability in test results. This feature is especially important in Legionella testing, where accuracy is critical for public health and safety.

Key Market Challenges

Lack of Standardized Testing Protocols

One of the primary challenges in the Legionella testing industry is the absence of standardized testing protocols. Different laboratories and testing facilities may use varying methods and equipment, leading to potential inconsistencies in results. Standardization is crucial to ensure that test results are accurate and can be reliably interpreted.

Key Market Trends

Rapid Diagnostic Tests

Rapid diagnostic tests are set to revolutionize the Legionella Testing Market. These tests offer quicker results, typically within hours, as opposed to the days required by traditional methods. Their speed and accuracy make them invaluable for timely decision-making in Legionella risk management. As demand for fast and reliable testing increases, rapid diagnostic tests will likely gain significant traction.

Key Market Players

• Abbott Laboratories
• Beckman Coulter, Inc.
• Bio-Rad Laboratories Inc.
• BIOMERIEUX SA
• Eiken Chemical Co., Ltd
• Hologic Inc.
• Pro-Lab PLC
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Legionella Testing Market, By Type:

• Water testing
• IVD testing

Legionella Testing Market, By End Use:

• Microbial culture
• Direct fluorescent antibody (DFA) stain
• PCR
• Others

Legionella Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.

Available Customizations:

Global Legionella Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Legionella Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Water testing, IVD testing)
  • 5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By End Use
  • 5.3.3. By Region

6. North America Legionella Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Water testing, IVD testing)
  • 6.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Legionella Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada Legionella Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico Legionella Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End Use

7. Europe Legionella Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Water testing, IVD testing)
  • 7.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Legionella Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End Use
  • 7.3.2. United Kingdom Legionella Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End Use
  • 7.3.3. France Legionella Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Legionella Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Legionella Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End Use

8. Asia-Pacific Legionella Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Water testing, IVD testing)
  • 8.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Legionella Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End Use
  • 8.3.2. Japan Legionella Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End Use
  • 8.3.3. India Legionella Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End Use
  • 8.3.4. Australia Legionella Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End Use
  • 8.3.5. South Korea Legionella Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End Use

9. South America Legionella Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Water testing, IVD testing)
  • 9.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Legionella Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Legionella Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Legionella Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Legionella Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Water testing, IVD testing)
  • 10.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Legionella Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Legionella Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Legionella Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End Use
  • 10.3.4. Kuwait Legionella Testing Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Recent Developments
  • 14.1.5. Financials (As Reported)
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Beckman Coulter, Inc.
• 14.3. Bio-Rad Laboratories Inc.
• 14.4. BIOMERIEUX SA
• 14.5. Eiken Chemical Co., Ltd
• 14.6. Hologic Inc.
• 14.7. Pro-Lab PLC
• 14.8. QIAGEN N.V.
• 14.9. F. Hoffmann-La Roche Ltd
• 14.10. Takara Bio Inc.
• 14.11. Thermo Fisher Scientific Inc.

15. Strategic Recommendations

16. About Us & Disclaimer